Sg3 Management, LLC Abb Vie Inc. Call Options Transaction History

Sg3 Management, LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $7.98 Million - $10.1 Million	-58,000 Reduced 74.36%	20,000 $3.06 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $2.18 Million - $2.7 Million	-16,500 Reduced 17.46%	78,000 $12.6 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $8.54 Million - $10.8 Million	79,500 Added 530.0%	94,500 $12.8 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $6.33 Million - $6.97 Million	-61,900 Reduced 80.49%	15,000 $1.62 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $5.38 Million - $7.27 Million	66,900 Added 669.0%	76,900 $8.24 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $945,010 - $1.11 Million	-11,000 Reduced 52.38%	10,000 $876,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $1.54 Million - $2.06 Million	21,000 New	21,000 $2.06 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $881,720 - $1.06 Million	-14,000 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $919,800 - $1.18 Million	14,000 New	14,000 $1.02 Million
Q2 2017 Jan 25, 2018	SELL	N/A	-7,200 Closed	0 $0
Q1 2017 Feb 26, 2018	BUY	N/A	7,128 Added 9900.0%	7,200 $469,000
Q1 2017 Jan 25, 2018	SELL	N/A	-17,128 Reduced 99.58%	72 $8,000
Q4 2016 Feb 23, 2018	BUY	N/A	17,028 Added 9900.0%	17,200 $1.08 Million
Q4 2016 Jan 24, 2018	BUY	N/A	172	172 $26,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.